RG
PLRX icon

Redmile Group’s Pliant Therapeutics PLRX Stock Holding History

Redmile Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$880K Hold
772,126
– – 0.06% 39
2026
Q1 		$973K Sell
772,126
-844,102
-52% -$1.07M 0.06% 35
2025
Q4 		$1.97M Buy
1,616,228
+24,533
+2% +$36.9K 0.15% 33
2025
Q3 		$2.36M Sell
1,591,695
-40,882
-3% -$62.4K 0.23% 36
2025
Q2 		$1.89M Sell
1,632,577
-420,982
-21% -$595K 0.2% 43
2025
Q1 		$2.77M Sell
2,053,559
-841,919
-29% -$5.11M 0.26% 45
2024
Q4 		$38.1M Sell
2,895,478
-302,013
-9% -$4.12M 2.66% 11
2024
Q3 		$35.8M Sell
3,197,491
-12,100
-0.4% -$151K 2.11% 23
2024
Q2 		$34.5M Buy
3,209,591
+112,371
+4% +$1.45M 2.09% 20
2024
Q1 		$46.1M Buy
3,097,220
+400,572
+15% +$6.61M 1.69% 22
2023
Q4 		$48.8M Buy
2,696,648
+18,549
+0.7% +$282K 1.75% 16
2023
Q3 		$46.4M Hold
2,678,099
– – 2.21% 9
2023
Q2 		$48.5M Sell
2,678,099
-247,549
-8% -$5.86M 1.86% 13
2023
Q1 		$77.8M Sell
2,925,648
-952,951
-25% -$27.1M 3.38% 6
2022
Q4 		$75M Sell
3,878,599
-629,605
-14% -$13.2M 3.07% 9
2022
Q3 		$94.2M Buy
4,508,204
+1,439,203
+47% +$27.5M 3.65% 5
2022
Q2 		$24.6M Sell
3,069,001
-11,800
-0.4% -$75.6K 0.94% 31
2022
Q1 		$21.6M Sell
3,080,801
-2,700
-0.1% -$27.6K 0.67% 40
2021
Q4 		$41.6M Hold
3,083,501
– – 0.95% 32
2021
Q3 		$52M Sell
3,083,501
-72,900
-2% -$1.55M 0.91% 35
2021
Q2 		$91.9M Sell
3,156,401
-50,792
-2% -$1.58M 1.36% 25
2021
Q1 		$126M Sell
3,207,193
-181,183
-5% -$5.88M 1.78% 16
2020
Q4 		$77M Sell
3,388,376
-3,381
-0.1% -$84.8K 0.93% 37
2020
Q3 		$76.8M Sell
3,391,757
-18,900
-0.6% -$472K 1.41% 23
2020
Q2 		$111M Buy
+3,410,657
New +$90.5M 2.04% 13

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Redmile Group's PLRX Position: Q2 2026 in Review

Redmile Group held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 772,126 shares worth $880K. The position accounts for 0.06% of the portfolio, ranked #39.

Redmile Group first reported a position in PLRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $126M in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Redmile Group held 772,126 shares of Pliant Therapeutics worth $880K as of Q2 2026.
  • Redmile Group left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up 0.06% of Redmile Group's portfolio in Q2 2026, its #39 holding.
  • Redmile Group first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 25 quarters since.
  • Redmile Group's Pliant Therapeutics position peaked at $126M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Redmile Group's 13F filing for Q2 2026, filed 14 Aug 2026.